GALMED PHARMACEUTICALS LTD. Cash and Cash Equivalents, Period Increase (Decrease)
GALMED PHARMACEUTICALS LTD. (GLMD) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.62 million for the 6-month period ending 2019-06-30, per its 6-K filed 2019-08-05.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-05
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|
| 2019-06-30 | $1.62M 6-K · filed 2019-08-05 | |
| 2018-12-31 | $11.14M 20-F · filed 2019-03-13 | |
| 2018-06-30 | -$6.87M 6-K · filed 2019-08-05 | |
| 2017-12-31 | $9.92M 20-F · filed 2019-03-13 | |
| 2017-06-30 | -$1.35M 6-K · filed 2018-08-02 | |
| 2016-12-31 | -$1.06M 20-F · filed 2019-03-13 | |
| 2016-06-30 | -$1.21M 6-K · filed 2017-07-31 | |
| 2015-12-31 | -$19.58M 20-F · filed 2018-03-13 | |
| 2015-06-30 | -$16.41M 6-K · filed 2017-06-23 | |
| 2014-12-31 | $23.60M 20-F · filed 2017-03-23 | |
| 2013-12-31 | -$581.00K 20-F · filed 2016-03-22 | |
| 2012-12-31 | $572.00K 20-F · filed 2015-03-31 |